Written by a preeminent expert on child and adolescent psychopharmacology, the Fourth Edition of this acclaimed reference is a current, authoritative clinical guide to the pediatric use of psychotropic drugs. For each class of drugs, Dr. Green offers practical advice on titration, dosing, maintenance therapy, discontinuation, and management of side effects. This thoroughly updated edition covers all new drugs and new drug formulations, particularly extended-release and qdextroq stimulant preparations. Dr. Green also reviews recent controlled clinical trials and examines current controversies regarding untoward effects of some drugs. Numerous tablesaincluding a new table on atypical antipsychoticsasummarize crucial information.Olanzapine is not approved for treatment of patients with dementia-related psychosis. Olanzapine ... Pharmacokinetics of Olanzapine Food does not affect the rate or extent of absorption of olanzapine. ... Olanzapine Pharmacokinetics In Child and Adolescent Inpatients Diagnosed with Schizophrenia Grothe et al. ( 2000)anbsp;...
|Title||:||Child and Adolescent Clinical Psychopharmacology|
|Author||:||Wayne H. Green|
|Publisher||:||Lippincott Williams & Wilkins - 2007|